Suppr超能文献

因脑膜炎球菌败血症入住重症监护病房的儿童的治疗结果。

The outcome of children admitted to intensive care with meningococcal septicaemia.

作者信息

Mok Q, Butt W

机构信息

Intensive Care Unit, Hospitals for Sick Children, London, UK.

出版信息

Intensive Care Med. 1996 Mar;22(3):259-63. doi: 10.1007/BF01712247.

Abstract

OBJECTIVE

To review our experience of children with meningococcal septicaemia, and to validate, in our group, severity scores used in different populations to predict outcome.

DESIGN

Retrospective review of case notes and charts.

PATIENTS

A total of 35 children were admitted to the paediatric intensive care unit (ICU) in the Royal Children's Hospital (RCH) in the 8 years between January 1985 and December 1992 with proven meningococcal septicaemia.

RESULTS

Ages ranged from 4 months to 16 years, with a median age of 20 months. The median meningococcal score was 4 and the median PRISM score was 20, with scores above these being significantly associated with death (P < 0.0001). Thirty-two children (91%) received infusions of colloid for hypovolaemia and twenty-nine (83%) received one or more inotropic drugs. Twenty-one children (60%) required mechanical ventilation for a median of 16.5 h (range 7-574). Seven children (20%) underwent plasmapheresis. Six children (17%) underwent haemofiltration and two (6%), peritoneal dialysis. One patient received extracorporeal membrane oxygenation (ECMO) because of circulatory failure. Twenty-one children (60%) developed disseminated intravascular coagulation, renal failure and/or skin or limb necrosis. The overall survival was 66%, and all survivors are functionally normal.

CONCLUSION

The mortality from the disease remains at 34% despite the technological advances in intensive care. The PRISM and meningococcal scores are useful in predicting outcome. Novel methods of treatment (e.g., plasmapheresis or ECMO) may be valuable.

摘要

目的

回顾我们治疗儿童脑膜炎球菌血症的经验,并在我们的研究组中验证用于不同人群预测预后的严重程度评分。

设计

对病例记录和图表进行回顾性研究。

患者

在1985年1月至1992年12月的8年期间,共有35名确诊为脑膜炎球菌血症的儿童入住皇家儿童医院(RCH)的儿科重症监护病房(ICU)。

结果

年龄范围为4个月至16岁,中位年龄为20个月。脑膜炎球菌血症评分中位数为4,PRISM评分中位数为20,高于这些分数与死亡显著相关(P<0.0001)。32名儿童(91%)因低血容量接受了胶体输注,29名儿童(83%)接受了一种或多种血管活性药物治疗。21名儿童(60%)需要机械通气,中位通气时间为16.5小时(范围7 - 574小时)。7名儿童(20%)接受了血浆置换。6名儿童(17%)接受了血液滤过,2名儿童(6%)接受了腹膜透析。1名患者因循环衰竭接受了体外膜肺氧合(ECMO)治疗。21名儿童(60%)发生了弥散性血管内凝血、肾衰竭和/或皮肤或肢体坏死。总体生存率为66%,所有幸存者功能正常。

结论

尽管重症监护技术取得了进步,但该疾病的死亡率仍为34%。PRISM和脑膜炎球菌血症评分有助于预测预后。新的治疗方法(如血浆置换或ECMO)可能很有价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验